Arkema : Information on the Financing of the Observation Period of Kem One
COLOMBES, France -- April 10, 2013
On March 27^th 2013, the Lyon commercial court opened insolvency proceedings
with continuation of activities for a six-month observation period against the
company Kem One SAS.
As part of the financing of the observation period, Arkema (Paris:AKE) points
out that its contribution amounts to €68.7million.
A part of this amount corresponds to the payment of contractual adjustments to
the selling price, which were provisioned for in the financial statements at
December 31^st 2012. The balance corresponds to certain guarantees granted by
the Group to third parties and made available to Kem One during the
The Group’s overall exposure to Kem One SAS remains estimated at an amount
close to €125million in total. Accordingly, Arkema will book a non-recurring
charge in its 1^st quarter 2013 financial statements for an equivalent amount.
A global chemical company and France’s leading chemicals producer, Arkema is
building the future of the chemical industry every day. Deploying a
responsible, innovation-based approach, we produce state-of-the-art specialty
chemicals that provide customers with practical solutions to such challenges
as climate change, access to drinking water, the future of energy, fossil fuel
preservation and the need for lighter materials. With operations in more than
40 countries, some 14,000 employees and 10 research centers, Arkema generates
annual revenue of €6.4 billion, and holds leadership positions in all its
markets with a portfolio of internationally recognized brands.
420, rue d’Estienne d’Orves – F-92705 COLOMBES Cedex – France
Standard : +33 (0)1 49 00 80 80 – Fax : +33 (0)1 49 00 83 96
Société anonyme au capital de 623 995 900 euros – 445 074 685 RCS Nanterre
Sophie Fouillat Tel.: +33 1 49 00 86 37
Jérome Raphanaud Tel.: +33 1 49 00 72 07
Gilles Galinier Tel.: +33 1 49 00 70 07
Press spacebar to pause and continue. Press esc to stop.